Allergy & Asthma Center, PC


Allergy & Asthma Center, P.C., is an allergy practice based in Eugene and Corvallis, Oregon.

Our practice includes allergists:

Appointments are available in the following locations in Oregon:

An allergist is a physician trained to diagnose, treat, and manage asthma and allergies, whether they are related to or caused by foods, environmental factors (such as pollen), drugs, or topical substances. Conditions that an allergist commonly treats include the following:

Important information regarding Insurance Coverage for Allergy and Asthma Care

For your information, each month we feature a topic of interest to our readers. Please read our current Topic of the Month below. To read previous articles that we have featured, please visit our Topic of the Quarter page.

Topic of the Quarter
May 2015

Immunotherapy treatment (allergy shots) is based on a century-old concept that the immune system can be desensitized to specific allergens that trigger allergy symptoms. These symptoms may be caused by allergic respiratory conditions, such as allergic rhinitis (hay fever) and asthma.

While common allergy medications often control symptoms, if you stop taking the medication(s), your allergy symptoms return shortly afterward. Allergy shots can potentially lead to lasting remission of allergy symptoms, and it may play a preventive role in terms of development of asthma and new allergies.

The Process

Treatment involves injecting the allergen(s) causing the allergy symptoms. These allergens are identified by a combination of a medical evaluation performed by a trained allergist/immunologist and allergy skin or allergy blood tests.

The treatment begins with a build-up phase. Injections containing increasing amounts of the allergens are given one to two times a week until the target dose is reached. This dose may be reached in three to six months with a conventional schedule (one dose increase per visit) but may be achieved in a shorter period of time with fewer visits with accelerated schedules, such as clusters that administer two to three dose increases per visit.

The maintenance phase begins when the target dose is reached. Once the maintenance dose is reached, the time between the allergy injections can be increased and generally range from every two to every four weeks. Maintenance immunotherapy treatment is generally continued for three to five years.

Some people have lasting remission of their allergy symptoms, but others may relapse after discontinuing immunotherapy; therefore, the duration of allergen immunotherapy varies from person to person.

Risks involved with the immunotherapy approach are rare, but they may include serious life threatening anaphylaxis. For that reason, immunotherapy should be given only under the supervision of a physician or qualified physician extender (nurse practitioner or physician assistant) in a facility equipped with proper staff and equipment to identify and treat adverse reactions to allergy injections.

The decision to begin immunotherapy will be based on several factors:

Another form of allergy immunotherapy was recently approved in the United States called sublingual immunotherapy (SLIT) allergy tablets. Rather than shots, allergy tablets involve administering the allergens under the tongue, generally on a daily basis.

Allergen Immunotherapy: still working after 100 Years

In 1911, both allergen immunotherapy and the electrical ignition system for cars were introduced. Although unrelated, these events share a common outcome. One paved the way for advances in transportation; the other led to advances in the treatment of allergies.

The earliest published successes for allergen immunotherapy were based on the work of two English scientists, Leonard Noon and John Freeman. Recognizing that pollen was the cause of hay fever, these scientists thought that they could induce immunity and tolerance by injecting hay fever patients with the pollen to which they were allergic.

This idea was based on the positive results of vaccine that produced protection against infectious diseases, such as smallpox.

Over the years, we’ve learned much more about allergen immunotherapy, including long-term benefits and what protocols are needed to make it very beneficial. Among the most important findings are that immunotherapy can provide long-term symptom relief for years after treatment is discontinued and that it is a cost-effective approach to treating many allergies.

Research has demonstrated that allergy immunotherapy can be effective in treating:

New Frontier

Currently, immunotherapy for food allergies is not recommended and strict avoidance of the food is advised; however, investigations with oral desensitization for food allergies are in progress in the United States.

Reprinted with permission from the American Academy of Allergy, Asthma & Immunology